Exhibit 99.1
| | | |
FOR IMMEDIATE RELEASE | | CONTACT: |
| | | Lisa Gould, Investor Relations |
| | | 617.779.7892 |
| | | lgould@amicas.com |
AMICAS REPORTS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND YEAR
ENDED DECEMBER 31, 2007
Positive cash flow from operations achieved for Q4 and the year
Boston, MA, February 28, 2008 /PRNewswire/ — AMICAS, Inc. (NASDAQ: AMCS), a leader in radiology and medical image and information management solutions, today reported unaudited financial results for the fourth quarter and year ended December 31, 2007.
Q4 Financial Highlights
Revenue: Total revenues for the fourth quarter of 2007 were $11.7 million compared to $11.4 million for the fourth quarter of 2006.
Operating Income/Loss: Operating loss for the fourth quarter of 2007 was $1.9 million compared to operating loss of $2.1 million for the fourth quarter of 2006.
Net Income/Loss: The Company’s net loss from continuing operations for the fourth quarter of 2007 was $902,000 or $(0.02) per share, compared to net loss from continuing operations of $1.1 million or $(0.03) per share, for the fourth quarter of 2006.
In the fourth quarter of 2007, both operating loss and net loss from continuing operations included a $0.3 million charge related to the elimination of the chief operating officer position, $0.3 million of non-cash stock-based compensation expense, and $0.8 million of depreciation and amortization. In the fourth quarter of 2006, operating loss and net loss from continuing operations included $0.4 million of non-cash stock-based compensation expense and $0.8 million for depreciation and amortization.
Cash and Cash Flow: AMICAS ended the fourth quarter of 2007 with a cash, cash equivalents, and marketable securities balance of $75.6 million, no long-term debt, and working capital of $69.5 million.
Fiscal Year Financial Highlights
Revenue: Total revenues for the year ended December 31, 2007, were $49.9 million compared to $49.4 million for the year ended December 31, 2006.
Operating Income/Loss: Operating loss for the year ended December 31, 2007, was $4.5 million compared to an operating loss of $4.9 million for the year ended December 31, 2006.
Net Income/Loss: The Company’s net loss from continuing operations for the year ended December 31, 2007, was $862,000, or $(0.02) per share, compared to a net loss from continuing operations of $1.3 million, or $(0.03) per share, for the year ended December 31, 2006.
For the year ended December 31, 2007, both operating loss and net loss from continuing operations included $1.9 million of stock-based compensation expense and $3.1 million of depreciation and amortization. For the year ended December 31, 2006, both operating loss and net loss from continuing operations included $0.5 million of non-recurring charges, $1.8 million of stock-based compensation expense, and $3.2 million of depreciation and amortization.
Cash Flow: For the year ended December 31, 2007, net cash provided by operations was $7.0 million as compared to net cash provided by operations of $3.6 million for the year ended December 31, 2006.
Stock Repurchase: During the fourth quarter of 2007, the Board of Directors directed the Company to initiate a $25.0 million stock repurchase plan. The Company repurchased approximately 301,000 shares of its common stock for approximately $0.8 million in the last quarter of 2007. Under a previously authorized stock repurchase plan, during 2006, the Company repurchased 4.5 million shares of its common stock for approximately $15.0 million, the total amount authorized by the AMICAS Board of Directors under the prior plan.
Business Perspective
Dr. Stephen Kahane, president, chief executive officer, and chairman of AMICAS, said, “Despite the challenges many companies have felt in this marketplace, AMICAS was able to grow bookings over 20 percent and enter into several very significant new customer partnerships in 2007. Several of the country’s largest radiology groups made decisions to use AMICAS products as the basis for their automation infrastructure going forward. Also, one of the largest imaging center enterprises in the country, MedQuest Associates, made the strategic decision to use AMICAS technology as their standard platform for image and information management. In the fourth quarter of 2007, AMICAS was able to sign several very sophisticated and informed imaging service providers. We will work hard to help these new partners succeed and to make sure others follow in their footsteps. It is noteworthy that, despite obstacles such as the Deficit Reduction Act (DRA) and other reimbursement pressures, these groups made the decision to take their automation support to the next level with industry leading offerings from AMICAS.”
Dr. Kahane went on to say, “While continuing to invest over 21 percent of our revenues in R&D costs and product enhancement purchases, AMICAS generated positive operating cash flow and ended the year with a strong cash and marketable securities balance, a strong recurring revenue base, and no debt. Everyone at AMICAS worked very hard to improve our operations and to help our customers and partners achieve their goals through the use of our innovative products and services. We believe that AMICAS is entering 2008 in a strong and very competitive position.”
“As we have said before, AMICAS remains committed to becoming the leading independent image and information management solutions provider in the healthcare industry. Now more than ever, we believe that our innovative end-to-end suite of products, our strong and experienced team of professionals, and our dedicated focus on image and information management will help our customers and partners by empowering them to grow, differentiate, and efficiently run their practices and businesses in 2008 and beyond.”
Dr. Kahane added, “AMICAS has entered 2008 energized, focused, and ready to work relentlessly to reach our goals and objectives and to become the leading independent vendor of choice in the image and information management marketplace.”
Looking Forward
AMICAS expects 2008 revenues to be between $52 million and $54 million, with pro-forma EBITDA expected to be between $1.0 million and $1.5 million, which is consistent with a net loss of approximately ($0.02) per share. EBITDA, a non-GAAP financial measure, refers to Net Income, adjusted for Amortization, Depreciation, Interest, and Stock Compensation expense.
A reconciliation of Net Income determined under GAAP to EBITDA is included below. Management believes that its EBITDA measurement, when viewed in addition to the Company’s reported GAAP results, provides an additional meaningful measure of operating performance, enabling investors to more thoroughly evaluate current performance in comparison to past performance. This information will necessarily differ from comparable information that may be provided by other companies and should not be considered in isolation or as an alternative to the Company’s operating and other financial information determined under GAAP.
- 2 -
Combining a market where imaging businesses continue to embrace automation as part of the response to the DRA with the combination of new product introductions already in progress, AMICAS expects 2008 bookings growth of between 10 to 20 percent. Bookings are defined as contractual commitments from customers for licenses, services, hardware, and maintenance/support.
Conference Call
AMICAS will host a conference call on Friday, February 29, at 8:30 a.m. Eastern Time to discuss the Company’s 2007 fourth fiscal quarter and year end results. Investors and other interested parties may dial in to the call using the toll free number 1-800-894-5910. (conference ID: 7AMICAS). The conference call will also be available via Webcast at www.amicas.com. Following the conclusion of the call, a replay will be available at 1-800-688-7339 or 402-220-1347 until March 28, 2008.
AMICAS, Vision Series, Vision Reach, RadStreamandAMICAS Insightare trademarks or registered trademarks of AMICAS, Inc.
About AMICAS, Inc.
AMICAS, Inc. (www.amicas.com) is a leader in radiology and medical image and information management solutions. The AMICAS® Vision Series™ products provide a complete, end-to-end solution for imaging centers, ambulatory care facilities, and radiology practices. Acute care and hospital clients are provided with a fully integrated, hospital information system-independent PACS that features advanced enterprise workflow support and scalable design. Complementing the Vision Series product family is AMICAS Insight™ Solutions, a set of client-centered professional and consulting services that assist our customers with a well-planned transition to a digital enterprise.
Safe Harbor Statement
Except for the historical information herein, the matters discussed in this release include forward-looking statements. In particular, the forward-looking statements contained in this release include statements about future financial and operating results. When used in this press release, the words: believes, intends, plans, anticipates, expects, estimates, and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause actual results to differ materially which include, but are not limited to, the following: a significant portion of the Company’s quarterly sales are concluded in the last month of the fiscal quarter; the length of sales and delivery cycles; the deferral and/or realization of deferred software license and system revenues according to contract terms; the timing, cost and success or failure of current and new product and service introductions and product upgrade releases; potential patent infringement claims against AMICAS and the related defense costs; the ability of AMICAS to comply with all government laws, rules and regulations; and other risks affecting AMICAS’ businesses generally and as set forth in AMICAS’ most recent filings with the Securities and Exchange Commission, including the section entitled “Risk Factors” of our most recent annual report on Form 10-K, and subsequent quarterly reports on Form 10-Q.All forward-looking statements in this release are qualified by these cautionary statements and are made only as of the date of this release.AMICAS is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise. The financial statements and information as of, and for the period ended, December 31, 2007 contained in this press release are subject to review by the Company’s independent registered public accounting firm.
- 3 -
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)
| | | | | | | | | |
| | | December 31, | | | December 31, | |
| | | 2007 | | | 2006 | |
Assets | | | | | | | | |
| Current assets: | | | | | | | | |
| Cash and cash equivalents | | $ | 8,536 | | | $ | 7,331 | |
| Marketable debt securities | | | 67,071 | | | | 64,436 | |
| Accounts receivable, net of allowances of $231 and $1,050, respectively | | | 10,483 | | | | 11,387 | |
| Prepaid expenses and other current assets | | | 3,600 | | | | 4,729 | |
| | | |
Total current assets | | | 89,690 | | | | 87,883 | |
| | | |
| | | | | | | | | |
| Property and equipment, less accumulated depreciation and amortization of $6,848 and $6,155, respectively | | | 1,186 | | | | 1,369 | |
| Goodwill | | | 27,313 | | | | 27,313 | |
| Acquired/developed software, less accumulated amortization of $7,992 and $6,035, respectively | | | 8,008 | | | | 7,665 | |
| Other intangible assets, less accumulated amortization of $1,742 and $1,316, respectively | | | 1,658 | | | | 2,084 | |
| Other assets | | | 586 | | | | 557 | |
| | | |
Total Assets | | $ | 128,441 | | | $ | 126,871 | |
| | | |
| | | | | | | | | |
Liabilities and stockholders’ equity | | | | | | | | |
| Current liabilities: | | | | | | | | |
| Accounts payable and accrued expenses | | $ | 9,820 | | | $ | 8,052 | |
| Deferred revenue, including unearned discounts of $0 and $336, respectively | | | 10,375 | | | | 10,867 | |
| | | |
| |
Total current liabilities | | | 20,195 | | | | 18,919 | |
| |
| Other liabilities, primarily unearned discounts re: outsourced printing services | | | — | | | | 397 | |
| | | |
| |
Commitments and contingencies | | | | | | | | |
| |
| Stockholders’ equity: | | | | | | | | |
| Preferred stock $.001 par value; 2,000,000 shares authorized; none issued | | | — | | | | — | |
| Common stock $.001 par value, 200,000,000 shares authorized, 51,296,823 and 51,066,966 issued, respectively | | | 51 | | | | 51 | |
| Additional paid-in capital | | | 229,056 | | | | 226,764 | |
| Accumulated other comprehensive income | | | 60 | | | | (4 | ) |
| Accumulated deficit | | | (98,478 | ) | | | (97,616 | ) |
| Treasury stock, at cost, 6,824,192 and 6,523,392 shares | | | (22,443 | ) | | | (21,640 | ) |
| | | |
Total stockholders’ equity | | | 108,246 | | | | 107,555 | |
| | | |
Total Liabilities and Stockholders’ Equity | | $ | 128,441 | | | $ | 126,871 | |
| | | |
- 4 -
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
| | | | | | | | | | | | | | | | | |
| | | Three Months Ended | | Year Ended |
| | | December 31, | | December 31, |
| | | 2007 | | 2006 | | 2007 | | 2006 |
| | | | | |
Revenues | | | | | | | | | | | | | | | | |
| Maintenance and services | | $ | 9,645 | | | $ | 8,991 | | | $ | 38,175 | | | $ | 36,258 | |
| Software licenses and system sales | | | 2,007 | | | | 2,453 | | | | 11,713 | | | | 13,179 | |
| | | | | |
| Total revenues | | | 11,652 | | | | 11,444 | | | | 49,888 | | | | 49,437 | |
| | | | | |
Costs and expenses | | | | | | | | | | | | | | | | |
| Cost of revenues: | | | | | | | | | | | | | | | | |
| Maintenance and services (a) | | | 4,134 | | | | 3,898 | | | | 16,469 | | | | 15,003 | |
| Software licenses and system sales, including amortization of software costs of $489, $489, $1,957 and $1,958, respectively | | | 1,326 | | | | 1,424 | | | | 6,486 | | | | 7,644 | |
| Selling, general and administrative (b) | | | 5,662 | | | | 5,866 | | | | 21,809 | | | | 21,770 | |
| Research and development (c) | | | 2,115 | | | | 2,075 | | | | 8,527 | | | | 8,705 | |
| Depreciation and amortization | | | 284 | | | | 294 | | | | 1,120 | | | | 1,238 | |
| | | | | |
| | | | 13,521 | | | | 13,557 | | | | 54,411 | | | | 54,360 | |
| | | | | |
Operating loss | | | (1,869 | ) | | | (2,113 | ) | | | (4,523 | ) | | | (4,923 | ) |
| Interest income | | | 991 | | | | 988 | | | | 3,870 | | | | 3,753 | |
| | | | | |
Loss from continuing operations, before income taxes | | | (878 | ) | | | (1,125 | ) | | | (653 | ) | | | (1,170 | ) |
| Provision for income taxes | | | 24 | | | | 21 | | | | 209 | | | | 84 | |
| | | | | |
Loss from continuing operations | | | (902 | ) | | | (1,146 | ) | | | (862 | ) | | | (1,254 | ) |
| Gain on sale of discontinued operations, net of taxes of $230 | | | — | | | | — | | | | — | | | | 230 | |
| | | | | |
Net loss | | $ | (902 | ) | | $ | (1,146 | ) | | $ | (862 | ) | | $ | (1,024 | ) |
| | | | | |
| | | | | | | | | | | | | | | | | |
Loss per share | | | | | | | | | | | | | | | | |
| Basic: | | | | | | | | | | | | | | | | |
| Continuing operations | | $ | (0.02 | ) | | $ | (0.03 | ) | | $ | (0.02 | ) | | $ | (0.03 | ) |
| Discontinued operations | | | 0.00 | | | | 0.00 | | | | 0.00 | | | | 0.00 | |
| | | | | |
| | | $ | (0.02 | ) | | $ | (0.03 | ) | | $ | (0.02 | ) | | $ | (0.03 | ) |
| | | | | |
| | | | | | | | | | | | | | | | | |
| Diluted: | | | | | | | | | | | | | | | | |
| Continuing operations | | $ | (0.02 | ) | | $ | (0.03 | ) | | $ | (0.02 | ) | | $ | (0.03 | ) |
| Discontinued operations | | | 0.00 | | | | 0.00 | | | | 0.00 | | | | 0.00 | |
| | | | | |
| | | $ | (0.02 | ) | | $ | (0.03 | ) | | $ | (0.02 | ) | | $ | (0.03 | ) |
| | | | | |
| | | | | | | | | | | | | | | | | |
Weighted average number of shares outstanding: | | | | | | | | | | | | | | | | |
| Basic | | | 44,746 | | | | 45,135 | | | | 44,657 | | | | 46,499 | |
| Diluted | | | 44,746 | | | | 45,135 | | | | 44,657 | | | | 46,499 | |
| | |
| (a) | | – includes $30,000, $107,000, $17,000 and $54,000 in stock-based compensation expense for the three and twelve months ended December 31, 2007 and December 31, 2006, respectively. |
| |
| (b) | | – includes $0.2 million, $1.5 million, $0.3 million and $1.5 million in stock-based compensation expense for the three and twelve months ended December 31, 2007 and December 31, 2006, respectively |
-5-
| | |
| (c) | | – includes $67,000, $267,000, $55,000 and $196,000 in stock-based compensation expense for the three and twelve months ended December 31, 2007 and December 31, 2006, respectively. |
-6-
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
| | | | | | | | | |
| | | Twelve Months Ended |
| | | December 31, |
| | | 2007 | | 2006 |
| | | |
Operating activities | | | | | | | | |
| Loss from continuing operations | | $ | (862 | ) | | $ | (1,254 | ) |
| Gain from discontinued operations | | | — | | | | 230 | |
| | | |
| Net loss | | | (862 | ) | | | (1,024 | ) |
| | | | | | | | | |
| Adjustments to reconcile net income (loss) to cash used in operating activities: | | | | | | | | |
| Gain from the sale of discontinued operations | | | — | | | | (230 | ) |
| Depreciation and amortization | | | 1,119 | | | | 1,238 | |
| Provisions for bad debts, returns and discounts | | | 185 | | | | 746 | |
| Gain on sale of fixed assets | | | — | | | | (6 | ) |
| Amortization of software development costs | | | 1,957 | | | | 1,958 | |
| Non-cash stock compensation expense | | | 1,878 | | | | 1,763 | |
| Changes in operating assets and liabilities: | | | | | | | | |
| Accounts receivable | | | 719 | | | | 3,184 | |
| Prepaid expenses and other | | | 1,100 | | | | (2,558 | ) |
| Accounts payable and accrued expenses | | | 1,768 | | | | (3,549 | ) |
| Deferred revenue including unearned discount | | | (889 | ) | | | 2,043 | |
| | | |
Cash provided by (used in) operating activities | | | 6,975 | | | | 3,565 | |
| | | |
| | | | | | | | | |
Investing activities | | | | | | | | |
| Proceeds from sale of assets | | | — | | | | 6 | |
| Purchases of property and equipment | | | (510 | ) | | | (921 | ) |
| Purchases of software | | | (2,300 | ) | | | — | |
| Purchases of held-to-maturity securities | | | (94,898 | ) | | | (49,094 | ) |
| Maturities of held-to-maturity securities | | | 100,263 | | | | 22,762 | |
| Purchases of available-for-sale securities | | | (45,275 | ) | | | (48,405 | ) |
| Sales of available-for-sale securities | | | 37,340 | | | | 10,297 | |
| | | |
Cash (used in) provided by investing activities | | | (5,380 | ) | | | (65,355 | ) |
| | | |
| | | | | | | | | |
Financing activities | | | | | | | | |
| Repurchase of common stock | | | (803 | ) | | | (15,168 | ) |
| Exercise of stock options and warrants | | | 413 | | | | 1,632 | |
| Tax benefit from change in valuation allow related to stock option exercises | | | — | | | | 443 | |
| | | |
Cash (used in) provided by financing activities | | | (390 | ) | | | (13,093 | ) |
| | | |
| | | | | | | | | |
Increase (decrease) in cash and cash equivalents | | | 1,205 | | | | (74,883 | ) |
| Cash and cash equivalents at beginning of year | | | 7,331 | | | | 82,214 | |
| | | |
Cash and cash equivalents at end of year | | $ | 8,536 | | | $ | 7,331 | |
| | | |
| | | | | | | | | |
Supplemental disclosure of cash paid during the period for: | | | | | | | | |
| Income taxes, net of refunds | | $ | 91 | | | $ | 2,425 | |
| | | |
Non-cash investing activities: | | | | | | | | |
| Unrealized gain (loss) on available-for-sale securities | | $ | 64 | | | $ | (4 | ) |
| | | |
- 7 -
| | | | | | | | | |
| | | 2008 Projected |
| | | Lower | | Upper |
| Reconciliation of projected net loss to projected EBITDA | | Range | | Range |
| Projected net loss | | $ | (1,350 | ) | | $ | (850 | ) |
| Interest income | | | 3,000 | | | | 3,000 | |
| | | |
| Operating loss | | | (4,350 | ) | | | (3,850 | ) |
| Non-cash stock compensation expense | | | 1,816 | | | | 1,816 | |
| Depreciation and amortization | | | 1,286 | | | | 1,286 | |
| Amortization of software development costs | | | 2,286 | | | | 2,286 | |
| | | |
Projected EBITDA | | | 1,037 | | | | 1,537 | |
| | | |
- 8 -
